Effector lymphocytes in autoimmunity

被引：65

作者：

Santamaria, P ^{[1
]}

机构：

[1] Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Calgary, AB T2N 4N1, Canada

来源：

CURRENT OPINION IN IMMUNOLOGY | 2001年 / 13卷 / 06期

基金：

加拿大健康研究院;

关键词：

D O I：

10.1016/S0952-7915(01)00276-X

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Autoimmune diseases result from complex interactions among different T- and B-lymphocyte subpopulations that target a rapidly growing number of autoantigens on different cell types. The etiology of most spontaneous autoimmune disorders, and both the kinetics and hierarchy of the underlying autoimmune responses are poorly understood. However, important advances have been made in recent years in our understanding of how autoreactive lymphocytes cause tissue damage, including the discovery that granzyme B binds to a cell surface receptor on target cells. This review is an attempt to summarize recent developments in this area.

引用

页码：663 / 669

页数：7

共 76 条

[41] Etanercept in children with polyarticular juvenile rheumatoid arthritis. [J].

Lovell, DJ ;

Giannini, EH ;

Reiff, A ;

Cawkwell, GD ;

Silverman, ED ;

Nocton, JJ ;

Stein, LD ;

Gedalia, A ;

Ilowite, NT ;

Wallace, CA ;

Whitmore, J ;

Finck, BK .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (11) :763-769

[42] IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis [J].

Lubberts, E ;

Joosten, LAB ;

Oppers, B ;

van den Bersselaar, L ;

Coenen-de Roo, CJJ ;

Kolls, JK ;

Schwarzenberger, P ;

van de Loo, FAJ ;

van den Berg, WB .

JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :1004-1013

[43] Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations [J].

Mackay, F ;

Woodcock, SA ;

Lawton, P ;

Ambrose, C ;

Baetscher, M ;

Schneider, P ;

Tschopp, J ;

Browning, JL .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (11) :1697-1710

[44] Unusual resistance of ALR/Lt mouse β cells to autoimmune destruction:: Role for β cell-expressed resistance determinants [J].

Mathews, CE ;

Graser, RT ;

Savinov, A ;

Serreze, DV ;

Leiter, EH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :235-240

[45] Fas ligand expression in thyroid carcinomas: A potential mechanism of immune evasion [J].

Mitsiades, N ;

Poulaki, V ;

Mastorakos, G ;

Tseleni-Balafouta, S ;

Kotoula, V ;

Koutras, DA ;

Tsokos, M .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08) :2924-2932

[46] Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus [J].

Moriwaki, M ;

Itoh, N ;

Miyagawa, J ;

Yamamoto, K ;

Imagawa, A ;

Yamagata, K ;

Iwahashi, H ;

Nakajima, H ;

Namba, M ;

Nagata, S ;

Hanafusa, T ;

Matsuzawa, Y .

DIABETOLOGIA, 1999, 42 (11) :1332-1340

[47] Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis [J].

Motyka, B ;

Korbutt, G ;

Pinkoski, MJ ;

Heibein, JA ;

Caputo, A ;

Hobman, M ;

Barry, M ;

Shostak, I ;

Sawchuk, T ;

Holmes, CFB ;

Gauldie, J ;

Bleackley, RC .

CELL, 2000, 103 (03) :491-500

[48] Genetic models for CNS inflammation [J].

Owens, T ;

Wekerle, H ;

Antel, S .

NATURE MEDICINE, 2001, 7 (02) :161-166

[49] In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor α [J].

Pakala, SV ;

Chivetta, M ;

Kelly, CB ;

Katz, JD .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) :1053-1062

[50]

Piguet PF, 1998, EUR J IMMUNOL, V28, P3499, DOI 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO

← 1 2 3 4 5 6 7 8 →